At a glance
ClinicalIndex Comparison RecordN/ACompleted· 2,741 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Impact of Systemic Manifestations/Comorbidities on Clinical State, Prognosis and Utilisation of Health Care Resources in Patients With COPD
In Brief
An observational study for Chronic Obstructive Pulmonary Disease (COPD). Completed, enrolled 2,741 participants across 22 sites.
Detailed Summary
The purpose of this study is to determine the prevalence and severity of extrapulmonary disorders and to quantify the impact of extrapulmonary organ manifestations on morbidity and mortality of COPD patients. Furthermore the investigators evaluate the relationship between systemic inflammation and organ involvement.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesGermany
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartNov 2010
First PostedNov 2010
Primary CompletionDec 2013
Study CompletionDec 2023
TodayJul 2026
First PostedNov 23, 2010
Enrollment StartNov 1, 2010
Primary CompletionDec 1, 2013
Study CompletionDec 1, 2023
TodayJul 2, 2026
Enrollment to primary: 3.1 yearsPosted 15.6 years ago